Theranos shifts from blood tests to product development for other labs
Thursday, October 6, 2016 - 03:31
in Mathematics & Economics
Shawn PricePALO ALTO, Calif., Oct. 6 (UPI) -- Theranos Inc. announced it is ceasing blood-testing and shifting to making products for other labs, a move that will cut 40 percent of the company's workforce.